Experts agree there are some concrete steps healthcare providers can take to ensure AI will be integrated more smoothly and equitably. Some of these measures include ensuring that models are trained on diverse datasets, keeping clinicians in the loop and prioritizing patient consent.
Read about news from Seven Bridges, HealthMine, Redi.Health, Xealth, and more.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Xealth, which was spun out of Providence, recently raised $24 million in a series B round. Advocate Aurora Enterprises led the round, bringing its health system backers to 14.
Xealth and Cerner had been working together after the health IT vendor invested in Xealth earlier this year. The companies brought on Banner Health as their first client.
Xealth, a company whose platform makes it easy to prescribe digital health tools and integrate them with patients’ health records, struck a partnership with Cerner. Both Cerner and LRVHealth invested $6 million into the startup.
Companies are employing AI to respond to the Covid-19 pandemic in a number of different ways, including diagnosing Covid-19 cases, identifying which patients would be at highest risk and discovering potential treatments. But not all of these approaches have been validated, experts warned.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The Seattle-based company, which spun out of Providence St. Joseph Health, has a platform that allows clinicians to prescribe and monitor digital health tools from their EHR workflows.
The Series A funding came from a slew of investors, including Novartis, Philips, McKesson Ventures, ResMed, Providence Ventures and UPMC.
The Seattle-based company's new feature will initially go live at two health systems: Providence St. Joseph Health and UPMC.
The president of UPMC's venture arm and it's innovation chief were among panelists explaining the benefits of having a hospital as an investor while asking for help from startups to transform the customer experience in healthcare.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Seattle-based Xealth, a new startup out of Providence Health & Services, has nabbed $8.5 million in a round led by DFJ. The company's platform lets physicians prescribe digital health content, apps and services.